![](/img/cover-not-exists.png)
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
Youngil Koh, Inho Kim, Sung-Soo Yoon, Byoung Kook Kim, Dae-Young Kim, Je-Hwan Lee, Kyoo-Hyung Lee, Eunkyung Park, Hyeoung-Joon Kim, Sang Kyun Sohn, Young Don Joo, Seok Jin Kim, Jooseop Chung, Ho-Jin SVolume:
89
Language:
english
Pages:
7
DOI:
10.1007/s00277-010-0910-8
Date:
July, 2010
File:
PDF, 127 KB
english, 2010